Range
€90 – €123.45
Live · Q2 2026EU markets,
EU markets,
in one feed.
The information layer behind ViraChem’s B2B web platform. Live spot prices, R&D news from open registries, and field research for pharmaceutical and biotech labs across Europe — sourced straight from our network of trade and refreshed hourly.
/ 02 Spot prices
Live price & analysis/ 7-day spot · €/g · 8 compounds
Updated hourlyAll compounds →
BPC-157 acetate
7d
€/g
€/g
€90/g▼-14.1%
−7d−5d−3d−1dnow
Vol 24h
—
Grade
Research
Epithalon acetate
7d
€/g
€/g
€93/g▲+50.5%
−7d−5d−3d−1dnow
Range
€92.37 – €103.91
Vol 24h
—
Grade
Research
GHK-cu acetate
7d
€/g
€/g
€4/g▲+80.9%
−7d−5d−3d−1dnow
Range
€3.3 – €4.35
Vol 24h
—
Grade
Research
Mots-c acetate
7d
€/g
€/g
€152/g▼-6.5%
−7d−5d−3d−1dnow
Range
€152 – €201.24
Vol 24h
—
Grade
Research
Compound · chemistry
7d trend
€/g · spot
1d · 7d · 30d
Volume
BPCBPC-157 acetate· raw powder
ResearchBulk · kilo-labacetate
CAS137525-51-0MW1419.5 g/molSaltacetateCID9941957SEQGEPPPGKPADDAGLVInChIHEEWEZGQMLZMFE-RKGINYAYSA-N
€90/g
1d-4.9%7d▼ -14.1%30d—
—
€90–123.45
EPIEpithalon acetate· raw powder
ResearchBulk · kilo-labacetate
CAS64082-79-7MW390.35 g/molSaltacetateCID219042SEQAEDGInChIHGHOBRRUMWJWCU-FXQIFTODSA-N
€93/g
1d-1.1%7d▲ +50.5%30d—
—
€92.37–103.91
GHKGHK-cu acetate· raw powder
ResearchBulk · kilo-labacetate
CAS89030-95-5MW401.91 g/molSaltacetateCID139035031SEQGly-His-Lys (Cu²⁺)InChILREZPQNYQZAPJC-ACMTZBLWSA-L
€4/g
1d-3.4%7d▲ +80.9%30d+80.9%
—
€3.3–4.35
MOTMots-c acetate· raw powder
ResearchBulk · kilo-labacetate
CAS1627580-64-6MW2174.6 g/molSaltacetateCID146675088SEQMRWQEMGYIFYPRKLRInChIWYTHCOXVWRKRAH-LOKRTKBUSA-N
€152/g
1d-2.4%7d▼ -6.5%30d—
—
€152–201.24
CJCCJC 1295 NO DAC acetate· raw powder
ResearchBulk · kilo-labacetate
CAS863288-34-0MW3367.9 g/molSaltacetateCID56841945SEQY-(D-A)-D-A-I-F-T-Q-S-Y-R-K-V-L-A-Q-L-S-A-R-K-L-L-Q-D-I-L-S-R-NH2InChIXOZMWINMZMMOBR-HRDSVTNWSA-N
€314/g
1d-4.9%7d▼ -6.0%30d—
—
€310.2–350.64
THYThymosin alpha 1 acetate· raw powder
ResearchBulk · kilo-labacetate
CAS62304-98-7MW3108.3 g/molSaltacetateCID16130571SEQSDAAVDTSSEITTKDLKEKKEVVEEAENInChINZVYCXVTEHPMHE-ZSUJOUNUSA-N
€496/g
1d+0.2%7d▲ +33.9%30d—
—
€478.08–534.55
THY2Thymosin beta-4 acetate· raw powder
ResearchBulk · kilo-labacetate
MW4963 g/molSaltacetateCID45382195InChIUGPMCIBIHRSCBV-UHFFFAOYSA-N
€377/g
1d+2.8%7d▲ +10.6%30d—
—
€332.42–377
THY3Thymulin acetate· raw powder
ResearchBulk · kilo-labacetate
CAS63958-90-7MW858.9 g/molSaltacetateCID71300623SEQXAKSQGGSNInChILIFNDDBLJFPEAN-YTAPOSPOSA-N
€147/g
1d+2.8%7d▲ +4.9%30d—
—
€119.82–147.72
Prices derive from ViraChem’s active network of trade, converted to EUR at the ECB daily reference rate for each transaction date. Methodology →
8 spots·€/g·ECB · EUR/USD —·Updated 00:06 CET·Q2 2026
/ 03 News pulse
News pulse & latest research/ open registries · blog
Updated hourlyFull feed →
R&D news feedEUROPE PMC · CT.GOV
29 MAY
TrialClinicalTrials.gov· PHASE3 · RECRUITING
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a …
National Cancer Institute (NCI)
29 MAY
TrialClinicalTrials.gov· PHASE3 · RECRUITING
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Researchers are looking for other ways to treat locally advanced or metastatic colorectal cancer (mCRC) that is unresectable and has a gene mutation called KRAS G12C. Standard (or usual) treatments for this type of co…
Merck Sharp & Dohme LLC
29 MAY
TrialClinicalTrials.gov· PHASE2 · ACTIVE_NOT_RECRUITING
Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer
This phase II trial studies the side effects and how well nivolumab works in treating patients with cervical cancer that has grown, come back, or spread to other places in the body. Monoclonal antibodies, such as nivo…
National Cancer Institute (NCI)
29 MAY
TrialClinicalTrials.gov· PHASE2 · ACTIVE_NOT_RECRUITING
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the canc…
National Cancer Institute (NCI)
29 MAY
TrialClinicalTrials.gov· PHASE1
Safety and Efficacy of PTH-IA
Jansen s Metaphyseal Chondrodysplasia (JMC) is a very rare disorder with only approximately 30 people known to have the disease worldwide. It is caused by parathyroid hormone 1 receptor (PTH1R) variants leading to con…
National Institute of Dental and Craniofacial Research (NIDCR)
29 MAY
TrialClinicalTrials.gov· PHASE2 · ACTIVE_NOT_RECRUITING
Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
This randomized phase II trial is studying how well giving ipilimumab with or without sargramostim (GM-CSF) works in treating patients with stage III or stage IV melanoma that cannot be removed by surgery (unresectabl…
National Cancer Institute (NCI)
Coming soon
Field notes and analysis from the ViraChem research desk. First posts land soon.
8 spots·€/g·ECB · EUR/USD —·Updated 00:06 CET·Q2 2026
/ 04 Methodology
Full methodology →How the data is built/ source · conversion · refresh
M · 01
Real-trade data
Every spot derives from actual orders moving through ViraChem’s EU trade network — not survey, not list-price scrape.
Source →M · 02ECB-converted EUR
Non-EUR transactions normalize to euros at the ECB daily reference rate for each trade date. Same convention across spots.
Conversion →M · 03Hourly refresh
Spot prices, trend deltas, and ticker rows refresh every hour. Each row carries a TTL so freshness is auditable downstream.
Cadence →8 spots·€/g·ECB · EUR/USD —·Updated 00:06 CET·Q2 2026
/ 06 Data sources
Europe PMCClinicalTrials.govUSPTObioRxivECB
Open registries · daily refresh/ the trade platformNeed to buy,
Need to buy,
not just read?
The B2B web platform — product catalogue, RFQ tools, analytical documentation, and EU shipping — lives at virachemical.com.
Visit virachemical.com/ what we do
Finished RUO formats, custom manufacturing, fill & finish, cosmetic white-label.
71 grade specs across 11 categories — Pharma, Cosmetic, Food, Analytical, IVD, Cell culture, Industrial, and others.
Browse services/ get a quote
RFQs & volume-tier quoting in 1 business day.
Tell us the compound, scale, and form. We come back with availability, lead time, and EU landed cost.
Request a quote